CenExel

When participants feel informed, supported, and respected throughout a study, it strengthens engagement, improves retention, and contributes to high-quality data. We're grateful to Luis for sharing his experience at CenExel Marlton, NJ, recognizing our team's professionalism, communication, and commitment to participant care. Every interaction matters. From first contact through study completion, our goal is to create an environment where participants feel comfortable, confident, and empowered throughout their research journey. Thank you to our Marlton team for delivering the level of care and operational excellence that helps build lasting trust with participants and confidence among our sponsors and CRO partners. Learn more about CenExel's integrated clinical research network: https://lnkd.in/etsZeuG #ClinicalResearch #PatientExperience #ClinicalOperations #ClinicalTrials #ResearchSites #CRO #Sponsors #HealthcareInnovation #CenExel

July is National Minority Mental Health Awareness Month, a time to recognize the importance of advancing equitable mental healthcare through research that reflects the diversity of the populations we serve. Mental health conditions affect people across every community, yet racial and ethnic minority populations have historically been underrepresented in clinical research. Increasing diversity in clinical trials helps generate more representative data, supports a better understanding of treatment responses across populations, and contributes to the development of therapies that may benefit a broader range of patients. At CenExel, we're committed to conducting inclusive, high-quality clinical research that helps move science forward while expanding access to research opportunities across diverse communities. By partnering with sponsors, CROs, healthcare providers, and patients, we strive to advance research that is both innovative and representative. Learn more about our therapeutic expertise and research capabilities: https://lnkd.in/etsZeuG #MinorityMentalHealthMonth #ClinicalResearch #HealthEquity #MentalHealthResearch #ClinicalTrials #DiversityInResearch #CRO #Biotech #Pharma #CenExel Together, we can help shape a future where mental healthcare is more inclusive and accessible for everyone. #MinorityMentalHealthMonth #MentalHealthAwareness #ClinicalResearch #ClinicalTrials #HealthEquity #MentalHealthResearch #CenExel

🌍 CenExel at AAIC 2026 Our team was proud to represent CenExel at the Alzheimer's Association®'s International Conference (AAIC) 2026 in London, UK, connecting with sponsors, CROs, researchers, and industry partners dedicated to advancing Alzheimer's and dementia research. Representing CenExel were: - George Hardie, MSc, MRSB, MICR – Senior Director, Tobacco Harm Reduction - Larry Ereshefsky PharmD, FCCP, BCPP – Chief Scientific Officer, Early Phase - Katherine Coerver, M.D., Ph.D., FAAN – Principal Investigator - Jeanette Caruso – Vice President, Early Phase Development (CROs) - Cecilia Mendez, Psy. D. – Senior Director, Business Development - Melanie Mestas – Event Manager - Zach Mitchell – Chief Commercial Officer Thank you to everyone who stopped by Booth 716. We enjoyed the conversations and look forward to building new partnerships that help advance neuroscience clinical research. #AAIC2026 #ClinicalResearch #Neuroscience #AlzheimersResearch #CenExel

Today is Chronic Disease Day. 💙 Chronic diseases affect nearly 6 in 10 U.S. adults, highlighting the ongoing need for innovative therapies and high-quality clinical research. At CenExel, we partner with sponsors to advance research across a wide range of chronic diseases through specialized research sites, experienced investigators, and dedicated study participants. Together, we help generate the data needed to evaluate potential new treatment options. Today, we recognize the patients, research professionals, and industry partners whose collaboration is helping shape the future of healthcare. Learn more about CenExel's therapeutic expertise and research capabilities at CenExelResearch.com. Source: Centers for Disease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion #ChronicDiseaseDay #ClinicalResearch #CRO #ClinicalOperations #DrugDevelopment #Biotech #Pharma #MedicalResearch #CenExel

We're excited to attend the 4th Annual Obesity & Weight Loss Drug Development Summit in Boston!   If you'll be there, connect with Lisa Lettiere, Senior Director, Business Development, Biotech, and Mark Gonzalez, Business Development Director, to learn how CenExel can support your obesity and metabolic clinical development programs.   We'd love to connect. See you July 14-16!   #ObesityResearch #ClinicalTrials #DrugDevelopment #Biotech #ClinicalResearch #CRO #WeightLossDrug

National PTSD Awareness Month highlights the ongoing need for innovation in behavioral health research. 💙 Despite its prevalence and impact, PTSD remains an area with significant unmet medical need. Advancing new treatment options requires strong partnerships across sponsors, CROs, sites, investigators, and participants. At CenExel, we're proud to support behavioral health and CNS development programs through specialized expertise, experienced investigators, and engaged patient communities. #PTSDAwarenessMonth #BehavioralHealth #CNSResearch #MentalHealthResearch #ClinicalResearch #ClinicalTrials #DrugDevelopment #Biotech #Pharma #CRO #CenExel

We're excited to be attending Alzheimer's Association® International Conference (AAIC) 2026 in London, July 12 to 15, 2026! Representing CenExel this year are: • Larry Ereshefsky PharmD, FCCP, BCPP, Chief Scientific Officer, Early Phase • Katherine Coerver, M.D., Ph.D., FAAN, Principal Investigator • Jeanette Caruso, VP, Early Phase Development (CROs) • Cecilia Mendez, Psy. D., Senior Director of Business Development • Zach Mitchell, Chief Commercial Officer Our team looks forward to connecting with researchers, sponsors, CROs, healthcare professionals, and industry partners to discuss the latest advancements in Alzheimer's disease and dementia research and explore opportunities to advance innovative clinical trials. If you're attending AAIC, we'd love to connect. See you in London! #AAIC2026 #AlzheimersResearch #ClinicalResearch #ClinicalTrials #Neuroscience

Behind every successful clinical trial is a dedicated team committed to advancing medicine. From patient recruitment and study coordination to site operations and participant care, research professionals play a critical role in delivering high-quality clinical trials and helping bring new therapies to patients. We're proud to work alongside sponsors, CROs, investigators, and study participants who make this work possible every day. Special thanks to our team at CenExel Decatur for sharing what inspires them to be part of clinical research. #ClinicalResearch #ClinicalTrials #DrugDevelopment #HealthcareInnovation #PatientCentricity #Biotech #Pharma #CRO #TeamCenExel #CenExel

We're proud to recognize Dr. Jada R., a double board-certified physician in Anesthesiology and Interventional Pain Management, for her outstanding contributions to clinical research and patient care! Since 2022, Dr. Reese has served as both a Sub-Investigator and Principal Investigator on multiple anesthesia and pain-focused studies, supporting sponsors including Vertex Pharmaceuticals, Ensysce Biosciences, Latigo Biotherapeutics, and Medtronic. Her work has helped advance innovative therapies designed to address acute postoperative pain and chronic pain management. Named a Top Doctor in the Atlanta area, Dr. Reese is recognized for her exceptional patient care, strong recruitment and retention performance, protocol excellence, and successful execution of complex clinical trials. We are grateful for her dedication to advancing research and helping bring new treatment options to patients who need them most. #CenExel #ClinicalResearch #PrincipalInvestigator #PainManagement #Anesthesiology #ClinicalTrials #ResearchExcellence #InnovationInResearch

June is Alzheimer's & Brain Awareness Month! Neurological and psychiatric disorders affect millions worldwide and remain among the greatest areas of unmet medical need. Advancing treatments for conditions such as Alzheimer's disease, Parkinson's disease, depression, anxiety, schizophrenia, and migraine disorders requires continued collaboration across sponsors, CROs, sites, and study participants. At CenExel, we're proud to support CNS research through specialized expertise, experienced investigators, and access to diverse patient populations. Learn more about our CNS capabilities: https://lnkd.in/etsZeuG #BrainAwarenessMonth #AlzheimersAwareness #CNSResearch #Neuroscience #ClinicalResearch #ClinicalTrials #DrugDevelopment #Biotech #Pharma #CenExel